Literature DB >> 21502317

Mitochondrial dysfunction impairs tumor suppressor p53 expression/function.

Shannon Compton1, Chul Kim, Nicholas B Griner, Prasanth Potluri, Immo E Scheffler, Sabyasachi Sen, D Joseph Jerry, Sallie Schneider, Nagendra Yadava.   

Abstract

Recently, mitochondria have been suggested to act in tumor suppression. However, the underlying mechanisms by which mitochondria suppress tumorigenesis are far from being clear. In this study, we have investigated the link between mitochondrial dysfunction and the tumor suppressor protein p53 using a set of respiration-deficient (Res(-)) mammalian cell mutants with impaired assembly of the oxidative phosphorylation machinery. Our data suggest that normal mitochondrial function is required for γ-irradiation (γIR)-induced cell death, which is mainly a p53-dependent process. The Res(-) cells are protected against γIR-induced cell death due to impaired p53 expression/function. We find that the loss of complex I biogenesis in the absence of the MWFE subunit reduces the steady-state level of the p53 protein, although there is no effect on the p53 protein level in the absence of the ESSS subunit that is also essential for complex I assembly. The p53 protein level was also reduced to undetectable levels in Res(-) cells with severely impaired mitochondrial protein synthesis. This suggests that p53 protein expression is differentially regulated depending upon the type of electron transport chain/respiratory chain deficiency. Moreover, irrespective of the differences in the p53 protein expression profile, γIR-induced p53 activity is compromised in all Res(-) cells. Using two different conditional systems for complex I assembly, we also show that the effect of mitochondrial dysfunction on p53 expression/function is a reversible phenomenon. We believe that these findings will have major implications in the understanding of cancer development and therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502317      PMCID: PMC3121470          DOI: 10.1074/jbc.M110.163063

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  101 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Molecular genetics of the mammalian NADH-ubiquinone oxidoreductase.

Authors:  I E Scheffler; N Yadava
Journal:  J Bioenerg Biomembr       Date:  2001-06       Impact factor: 2.945

3.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Authors:  Ian P M Tomlinson; N Afrina Alam; Andrew J Rowan; Ella Barclay; Emma E M Jaeger; David Kelsell; Irene Leigh; Patricia Gorman; Hanan Lamlum; Shamima Rahman; Rebecca R Roylance; Simon Olpin; Stephen Bevan; Karen Barker; Nicholas Hearle; Richard S Houlston; Maija Kiuru; Rainer Lehtonen; Auli Karhu; Susa Vilkki; Päivi Laiho; Carita Eklund; Outi Vierimaa; Kristiina Aittomäki; Marja Hietala; Pertti Sistonen; Anders Paetau; Reijo Salovaara; Riitta Herva; Virpi Launonen; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2002-02-25       Impact factor: 38.330

4.  Phosphorylation site interdependence of human p53 post-translational modifications in response to stress.

Authors:  Shin'ichi Saito; Hiroshi Yamaguchi; Yuichiro Higashimoto; Connie Chao; Yang Xu; Albert J Fornace; Ettore Appella; Carl W Anderson
Journal:  J Biol Chem       Date:  2003-07-14       Impact factor: 5.157

5.  Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.

Authors:  Andrew M Roberts; Ian R Watson; Andrew J Evans; David A Foster; Meredith S Irwin; Michael Ohh
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

6.  The role of the ESSS protein in the assembly of a functional and stable mammalian mitochondrial complex I (NADH-ubiquinone oxidoreductase).

Authors:  Prasanth Potluri; Nagendra Yadava; Immo E Scheffler
Journal:  Eur J Biochem       Date:  2004-08

7.  Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.

Authors:  Anna M Ray; Kimberly A Zuhlke; Albert M Levin; Julie A Douglas; Kathleen A Cooney; John A Petros
Journal:  Prostate       Date:  2009-06-15       Impact factor: 4.104

8.  Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.

Authors:  M R Abedini; E J Muller; R Bergeron; D A Gray; B K Tsang
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

9.  Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity.

Authors:  Shaolei Lu; Klaus A Becker; Mary J Hagen; Haoheng Yan; Amy L Roberts; Lesley A Mathews; Sallie S Schneider; Hava T Siegelmann; Kyle J MacBeth; Stephen M Tirrell; Jeffrey L Blanchard; D Joseph Jerry
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

10.  Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

Authors:  Celine Perier; Kim Tieu; Christelle Guégan; Casper Caspersen; Vernice Jackson-Lewis; Valerio Carelli; Andrea Martinuzzi; Michio Hirano; Serge Przedborski; Miquel Vila
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

View more
  31 in total

Review 1.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

2.  Mapping mitochondrial respiratory chain deficiencies by respirometry: Beyond the Mito Stress Test.

Authors:  Sausan M Jaber; Nagendra Yadava; Brian M Polster
Journal:  Exp Neurol       Date:  2020-03-09       Impact factor: 5.330

Review 3.  Adipose tissue dysfunction and its effects on tumor metabolism.

Authors:  Jonathan Diedrich; Halina Chkourko Gusky; Izabela Podgorski
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

Review 4.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

5.  Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.

Authors:  Trevor Carden; Bhupendra Singh; Ved Mooga; Prachi Bajpai; Keshav K Singh
Journal:  J Biol Chem       Date:  2017-10-24       Impact factor: 5.157

Review 6.  Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology?

Authors:  Jie Zhuang; Wenzhe Ma; Cory U Lago; Paul M Hwang
Journal:  Free Radic Biol Med       Date:  2012-07-25       Impact factor: 7.376

7.  Neem oil limonoids induces p53-independent apoptosis and autophagy.

Authors:  Pragya Srivastava; Neelu Yadav; Ravi Lella; Andrea Schneider; Anthony Jones; Timothy Marlowe; Gabrielle Lovett; Kieran O'Loughlin; Hans Minderman; Raghu Gogada; Dhyan Chandra
Journal:  Carcinogenesis       Date:  2012-08-21       Impact factor: 4.944

Review 8.  Impaired mitochondrial metabolism and mammary carcinogenesis.

Authors:  Nagendra Yadava; Sallie S Schneider; D Joseph Jerry; Chul Kim
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-12-27       Impact factor: 2.673

Review 9.  Mitochondrial DNA mutations and breast tumorigenesis.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Biochim Biophys Acta       Date:  2013-10-16

10.  Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.

Authors:  Raj K Gopal; Kirsten Kübler; Sarah E Calvo; Paz Polak; Dimitri Livitz; Daniel Rosebrock; Peter M Sadow; Braidie Campbell; Samuel E Donovan; Salma Amin; Benjamin J Gigliotti; Zenon Grabarek; Julian M Hess; Chip Stewart; Lior Z Braunstein; Peter F Arndt; Scott Mordecai; Angela R Shih; Frances Chaves; Tiannan Zhan; Carrie C Lubitz; Jiwoong Kim; A John Iafrate; Lori Wirth; Sareh Parangi; Ignaty Leshchiner; Gilbert H Daniels; Vamsi K Mootha; Dora Dias-Santagata; Gad Getz; David G McFadden
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.